Heartflow, Inc.
HTFL Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 27, 2026
$57.82
KIRA · Stoqly’s AI analyst, in plain words
- Heartflow, Inc. had $176M of revenue in fiscal 2025, up 39.9% on the year before.
- Its operating margin was −36.4%, up 12.3 pts: of every 100 in sales, about −36 is left after running the business.
- Heartflow, Inc. lost $117M in fiscal 2025.
- Free cash flow was −$59.0M in fiscal 2025, −33.5% of revenue.
Market cap
$5.0B
P/E
19.0x
Revenue
$176M
Net income
−$117M
Free cash flow
−$59.0M
Operating margin
−36.4%
Heartflow, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+39.9%
Yes. Sales grew 39.9% last year.
Does it make a profit?
−66.3%
No. It lost money last year.
Does profit turn into cash?
−33.5%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
How is the share priced?
19.0x
One share costs 19.0 times its yearly profit per share.
What Heartflow, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 18, 2026
- Legal name
- Heartflow, Inc.
- CIK
- 0001464521
Heartflow, Inc. · HTFL
Results and finances
The last 3 fiscal years. Amounts in USD.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Sales and profit | |||
| Revenue | $87.2M | $126M | $176M |
| Revenue growth | — | 44.3% | 39.9% |
| Gross margin | 66.6% | 75.1% | 76.8% |
| Operating margin | −83.6% | −48.7% | −36.4% |
| Net income | −$95.7M | −$96.4M | −$117M |
| Net margin | −109.7% | −76.6% | −66.3% |
| Diluted EPS | −$25.32 | −$17.98 | −$3.17 |
| Cash | |||
| Cash from operations | −$76.4M | −$69.0M | −$54.0M |
| Capital expenditure | $6.1M | $4.4M | $5.0M |
| Free cash flow | −$82.5M | −$73.4M | −$59.0M |
| FCF margin | −94.7% | −58.3% | −33.5% |
| Share buybacks | $0.2M | — | — |
| Share count change | — | 9.8% | 587.1% |
| Debt and strength | |||
| Cash and short-term investments | $123M | $51.4M | $177M |
| Shareholders' equity | −$778M | −$859M | $301M |
| Current ratio | — | 2.4x | 5.2x |
| Interest coverage | −3.0x | −2.7x | −4.2x |
| Returns and quality | |||
| Return on tangible equity | — | — | −38.8% |
| Piotroski F-score | — | — | 4 |
| Altman Z'' | — | −31.7 | −2.4 |
Insiders bought, 12 months
$1.1M
1 insider
Insiders sold, 12 months
$141M
6 insiders
Of sales under plans
19%
$26.3M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Heartflow, Inc. · HTFL
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $57.82 a share, the company is worth $5.0B: 19.0 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001464521). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.